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Abstract
The study assesses complexity of the cardiac control directed to the sinus node and to ventricles in long QT syndrome type
1 (LQT1) patients with KCNQ1-A341V mutation. Complexity was assessed via refined multiscale entropy (RMSE) computed
over the beat-to-beat variability series of heart period (HP) and QT interval. HP and QT interval were approximated
respectively as the temporal distance between two consecutive R-wave peaks and between the R-wave apex and T-wave
end. Both measures were automatically taken from 24-hour electrocardiographic Holter traces recorded during daily
activities in non mutation carriers (NMCs, n = 14) and mutation carriers (MCs, n = 34) belonging to a South African LQT1
founder population. The MC group was divided into asymptomatic (ASYMP, n = 11) and symptomatic (SYMP, n = 23)
patients according to the symptom severity. Analyses were carried out during daytime (DAY, from 2PM to 6PM) and
nighttime (NIGHT, from 12PM to 4AM) off and on beta-adrenergic blockade (BBoff and BBon). We found that the complexity
of the HP variability at short time scale was under vagal control, being significantly increased during NIGHT and BBon both
in ASYMP and SYMP groups, while the complexity of both HP and QT variability at long time scales was under sympathetic
control, being smaller during NIGHT and BBon in SYMP subjects. Complexity indexes at long time scales in ASYMP
individuals were smaller than those in SYMP ones regardless of therapy (i.e. BBoff or BBon), thus suggesting that a reduced
complexity of the sympathetic regulation is protective in ASYMP individuals. RMSE analysis of HP and QT interval variability
derived from routine 24-hour electrocardiographic Holter recordings might provide additional insights into the physiology
of the cardiac control and might be fruitfully exploited to improve risk stratification in LQT1 population.
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Introduction
The long QT syndrome is an inherited disease characterized by
a prolonged ventricular repolarization duration, leading to a
longer QT interval on the surface ECG [1,2]. Long QT syndrome
patients are at very high risk for life-threatening arrhythmias, such
as torsades de pointes, and to sudden death [1,2]. Several genetic
mutations have been associated to long QT syndrome and one of
the most common is the mutation on the KCNQ1 gene leading to
long QT syndrome type 1 (LQT1). The occurrence of LQT1
symptoms is often precipitated by physiological conditions, such as
physical or emotional stress, associated with an augmented
sympathetic activity and an increased heart rate in a genotype-
specific manner [3]. Although LQT1 is well coded in terms of
genetic correlates, the same mutation can lead to totally different
phenotypes or even to a complete absence of symptoms [2]. As a
matter of fact, autonomic control can modulate the severity of
LQT1. More specifically, the reactivity of the vagal control,
estimated through the assessment of the cardiac baroreflex
sensitivity and through the magnitude of the bradycardic response
following exercise stress test, is helpful to divide a group carrying
the same KCNQ1 mutation into symptomatic (SYMP) and
asymptomatic (ASYMP) patients [4,5]. Autonomic function might
be modified in LQT1 patients and its assessment might provide
the key for devising more powerful therapies and for improving
risk stratification.
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The spontaneous variations of heart period (HP) and QT
interval provide indexes helpful to infer the state of the autonomic
nervous system. For example, the power of HP variability in the
high frequency (HF, from 0.15 to 0.4 Hz) band is a marker of
vagal modulation directed to the sinus node [6,7], being abolished
by cholinergic blockade [8]. Conversely, QT variability is more
under sympathetic control especially if the sympathetic drive is
relevant [9–17]. This link was confirmed using a stimulus
progressively increasing the sympathetic drive such as the graded
head-up tilt test [18–20]: indeed, it was found that the amount of
the QT changes in the low frequency (LF, from 0.04 to 0.15 Hz)
band and the magnitude of the QT variations independent of HP
changes increased with the relevance of the orthostatic challenge
correlated with the inclination of the tilt table [10,21]. Although
linear indexes, such as the powers of the HP and QT variations in
specific frequency bands, are largely utilized to infer the
autonomic profile, there is an increasing amount of evidences
that non linear indexes measuring the complexity of the cardiac
control from HP and QT series might be more sensitive than the
linear markers in the case of pathological conditions [22]. This
propensity might come from their preserved relation with the state
of the autonomic nervous system [23], their ability in accounting
for non linear dynamics [22] and their link with the derangement
of the cardiovascular control from a different perspective
compared to the most frequently utilized autonomic markers
based on the magnitude of HP and QT variations [24,25].
We hypothesize that the complexity analysis of the HP and QT
variability could be fruitfully exploited to characterize the LQT1
population and, more specifically, might contribute to differentiate
patients with the same genetic defect but with completely different
risks of cardiac events (i.e. ASYMP and SYMP groups).
Unfortunately, since the HP and QT variability cannot be
adequately modeled according to a sum of few periodic
components, a single scale analysis might underestimate the
complexity of the cardiac control and might have a limited power
in distinguishing different groups, especially if they featured the
same genotype. Conversely, the assessment of the HP and QT
variability complexity as a function of the temporal scales might
circumvent the limitations of single scale analysis [26].
The aim of this study was to perform the complexity analysis of
the HP and QT variability to characterize cardiovascular control
and favor the differentiation between ASYMP and SYMP
patients. The availability of ASYMP and SYMP patients, all
descendants from the same family originally settled in South Africa
in 1690 [27] and carrying the same KCNQ1-A341V mutation,
provides the unique possibility to study the adaptation process
followed by the SYMP patients to limit the consequences of their
genetic defect and the inner relation between genotype and
phenotype [28–30]. As a matter of fact, the availability of a
founder population such as this one offer the best chances for the
identification of factors modifying the risk for life-threatening
arrhythmias [31].
Complexity analysis was performed through multiscale entropy
(MSE), first introduced by Costa et al [32] and subsequently
refined by Valencia et al [33]. MSE allows the quantification of
complexity of a time series as a function of the temporal scale, thus
targeting specific control mechanisms concurring to the HP and
QT regulation.
Methods
Generalities of MSE
MSE is a technique estimating the complexity of a time series
x = {x(i), i = 1,…,N}, where i is the sample counter and N is the
series length, via entropy rate at different time scales [32]. It
consists of three steps performing: i) the elimination of the fast
temporal scales via a low pass filtering procedure, thus obtaining
the filtered series, xf = {xf(i), i = 1,…,N}, that focuses the frequency
range of interest; ii) the downsampling of xf with a scale factor, t,
chosen according to the cutoff of the low pass filter exploited for
canceling fast oscillations, thus obtaining the filtered downsampled
series, xf
t={xf
t(j), j = 1,…,N/t}; iii) the computation of an entropy
rate over xf
t as a function of t. In this work we exploited a refined
version of the MSE, the refined MSE (RMSE), devised to fix two
biases present in the computation of the MSE [33].
MSE and RMSE
The elimination of the fast temporal scales in MSE is carried out
using a low pass finite impulse response filter performing the mean
of t samples (i.e. all coefficients of the filter are set to 1/t) [32].
Since the frequency response of this filter is very poor being
characterized by a slow roll-off of the main lobe, a large transition
band and important side lobes, aliasing is not prevented when the
filtered series is downsampled at a rate of one sample every t.
RMSE substitutes the low pass finite impulse response filter with a
low pass Butterworth filter of order 6 having a cutoff frequency
equal to 0.5/t cycles/sample [33]. This filter has a flat response in
the pass band, no side lobes in the stop band and a faster roll-off,
thus being more efficient in limiting aliasing during downsampling.
The low pass filtered series is downsampled at a rate of one sample
every t, thus reducing the total number of values from N to N/t.
The complexity of the low pass filtered series is estimated via the
sample entropy [34]. Let us label the negative logarithm of
the probability of finding two patterns of length L, xf,L
t(j) = [xf
t(j),
xf
t(j-1),…, xf
t(j-L+1)] and xf,Lt(k) = [xft(k), xft(k-1),…, xft(k-L+1)]
with L#j,k#N/t at distance closer than a parameter r as W(L,r).
The sample entropy is defined as the difference between W(L,r)
and W(L-1,r), thus quantifying the probability that, if xf,L-1
t(j) and
xf,L-1
t(k) are nearby in the embedding space of dimension L-1, they
will remain nearby in the embedding space of dimension L [34]. r
is usually referred to as tolerance for the calculation of the sample
entropy and sets the level of coarse graining of the embedding
space (i.e. patterns at distance closer than r cannot be distinguished
as separated entities under the adopted level of discretization of the
embedding space. In MSE r was set as a percentage of the
standard deviation of x (usually the 15%) and it was kept constant
as a function of t [32]. Since the low pass filtering procedure
reduces the standard deviation of the series, the region of the
embedding space occupied by the patterns decreases more and
more with t and, consequently, the number of pairs of patterns
becoming closer and closer increases with t, thus leading to a
decrease of the sample entropy. This complexity reduction is
artificial because it is solely the effect of the decline of variance
with t. In RMSE r is set as a percentage of the standard deviation
of xf
t, thus continuously updating r with t [33].
Study population, experimental protocol and data
analysis
Ethics statement. The study adhered to the principles of the
Declaration of Helsinki for medical research involving humans. It
was approved by the ethical review boards of the Universities of
Stellenbosch, Vanderbilt and Pavia. All probands and family
members provided written informed consent for clinical and
genetic evaluations, as approved by the ethical review boards of
the Universities of Stellenbosch, Vanderbilt and Pavia. Written
informed consent was obtained from the next of kin, caretakers or
guardians on behalf of minors enrolled in the study. Full access to
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this database is available free of charge by contacting the
corresponding author.
Study population and Holter recordings. Twelve lead 24-
hour Holter recordings were acquired from 48 different individ-
uals (age from 16 to 62, median = 41; 19 males) who were all
heterozygous for the KCNQ1-A341V mutation and were
members of a LQT1 founder population [27,28]. The group
was composed of 14 non mutation carriers (NMCs) (age from 19 to
56, median= 36.5; 6 males) and 34 mutation carriers (MCs). The
MC group consisted of 11 ASYMP subjects (age from 24 to 62,
median = 46; 4 males) and 23 SYMP individuals (age from 16 to
57, median= 39; 9 males).
While all NMC subjects were recorded only BBoff, 7 ASYMP
and 22 SYMP subjects were recorded both on beta-blocker
therapy (BBon) and off (BBoff). The remaining 5 MC individuals
(i.e. 4 ASYMP and 1 SYMP) were acquired only BBoff. Beta-
blocker therapy was quite homogeneous among the MC subjects
with the majority of the patients (i.e. 86%) treated with
propranolol.
The total number of recordings was 77: 14 traces from NMC
recorded only BBoff, 58 recordings from 7 ASYMP and 22 SYMP
acquired both BBoff and BBon, and 5 traces from 4 ASYMP and 1
SYMP recorded only BBoff. The majority of the recordings (i.e.
92%) were acquired using equipment from Mortara Instrument
(Mortara Instrument Inc., Milwaukee, WI, USA) and the
remaining subjects were studied using equipment from Ela
Medical (Sorin Group, Arvada, CO, USA). Sampling rate was
180 Hz for Mortara and 200 Hz for Ela Medical recordings.
Amplitude resolution was 6.25 and 10 mV for Mortara and Ela
Medical recordings respectively. Analyses were carried out on the
lead with the best signal-to-noise ratio. In the case of multiple
recordings over the same subject, the procedure for lead selection
prevented the choice of different leads over the same subject.
Analyses were performed during daytime (DAY, from 2 PM to 6
PM) and nighttime (NIGHT, from 12 PM to 4 AM). The subjects
were not asked to follow any specific behavioral procedure during
the considered periods. Diaries of each subject were checked to
ensure that the individual did not sleep during DAY period or
remained awake during the NIGHT period. Sequences of 5000
consecutive HP and QT measures were randomly selected in the
DAY and NIGHT periods.
Experimental protocol. We carried out three different
comparisons. The first comparison checked the differences
attributable to the genotype in the period most at risk for LQT1
patients (i.e. DAY) under the hypothesis that genotype affects the
complexity of the cardiovascular control: we contrasted MC
patients with NMC individuals BBoff during DAY (i.e. NMC-MC
protocol). The second comparison evaluated the influence of the
state of the autonomic nervous system on the considered
parameters under the hypothesis that autonomic function can
modulate the risk in LQT1 patients: we compared SYMP and
ASYMP groups BBoff during DAY and NIGHT (i.e. DAY-
NIGHT protocol). The third comparison evaluated the effect of
beta-blocker therapy on the considered parameters in the period
most at risk for LQT1 patients (i.e. DAY) under the hypothesis
that beta-blocker therapy can affect the risk profile: we contrasted
SYMP and ASYMP patients both BBoff and BBon during DAY
(i.e. BBoff-BBon protocol).
Extraction of the HP and QT variabilities. HP was
computed as the temporal distance between two consecutive R-
wave apexes fixed with minimum jitters using parabolic interpo-
lation. The QT interval was approximated as the time distance
between R-wave peak and T-wave end. The T-wave end was
located using a threshold set as a fraction of the maximal absolute
first derivative computed on the T-wave downslope [35]. We make
reference to [35] for ECG preprocessing procedures, baseline
wandering removal and parameter settings for fiducial point
delineation. The R-wave peak delimiting the i-th QT interval was
the one defining the end of the i-th HP. All the parameters for R-
wave apex and T-wave end recognition were continuously
updated during the analysis and the detections were carefully
checked. HP and QT series were not corrected except in case of
premature ventricular contractions or evident arrhythmias. In
these cases cubic spline interpolation was performed over the
values to correct and the number of corrections was always lower
than 5% of the total measures in the considered period of analysis.
HP and QT variability analyses. RMSE was computed
over HP and QT series with t ranging from 1 to 12. The time
scales at t=1, t ranging from 2 to 4, and t ranging from 5 to 12
were defined as short, medium and long time scales respectively.
According to the cutoff of the Butterworth filter (i.e. 0.5/t cycles/
sample) performing the analysis with t=1 is equivalent to
traditional complexity analysis over the original unfiltered HP
and QT series (i.e. from 0.0 to 0.5 cycles/beat). This analysis
assesses the complexity of all temporal scales present in the HP and
QT variability, being largely influenced by the fastest ones present
in the original unfiltered series. Conversely, pooling together
RMSE values assessed at medium time scales allowed the compact
representation of the complexity at medium time scales: indeed,
while varying t from 2 to 4 the superior limit of the considered
oscillations was reduced from 0.25 to 0.125 Hz with a HP mean of
1 s. This means that RMSE measures was calculated by getting rid
of the contribution of the temporal scales above 0.25 Hz, by
considering the contribution of respiratory oscillations (progres-
sively canceled while increasing t from 2 to 4) and by accounting
for rhythms slower than the respiratory ones. Therefore, since
complexity analysis is mainly influenced by the shortest time scale
present in the series, this group of RMSE measures was primary
affected by the contribution of oscillations present in the HF band.
Finally, pooling together RMSE values assessed at long time scales
allowed the compact representation of the complexity at long time
scales: indeed, while varying t from 5 to 12 the superior limit of
the considered oscillations was reduced from 0.1 to 0.042 Hz with
a HP mean of 1 s. As a consequence this group of RMSE
measures was assessed after deleting fast periodicities including
those in the HF band, thus accounting for the influences of
rhythmicities in the LF band. According to this classification
RMSE values were averaged over short, medium and long time
scales and the mean value was labeled as RMSEt=1, RMSEt=2–4
and RMSEt=5–12 in the following.
Statistical analysis. We performed the paired t-test to check
the significance of the difference between RMSE indexes derived
from HP and QT series regardless of the considered group in each
experimental protocol. If the normality test (Kolmogorov-Smirnov
test) was not fulfilled, Wilcoxon signed rank test was utilized. One
way analysis of variance (Holm-Sidak test for multiple compari-
sons), or Kruskal-Wallis one way analysis of variance on ranks
(Dunn’s method for multiple comparisons) when appropriate, was
applied to check the significance of the differences between
ASYMP, SYMP and NMC groups BBoff during DAY. Two way
repeated measures analysis of variance (one factor repetition,
Holm-Sidak test for multiple comparisons) was utilized to assess
the significance of the differences between ASYMP and SYMP
individuals BBoff in relation to the period of analysis (i.e. DAY and
NIGHT) and between SYMP and ASYMP patients during DAY
in relation to therapy (i.e. BBoff and BBon). Statistical analysis was
carried out using a commercial statistical program (Sigmaplot,
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Systat Software, Inc, Chicago, IL, ver.11.0). A p,0.05 was always
considered as significant.
Results
Time domain analysis
Table 1 shows mean and variance of the HP and QT series in
the NMC-MC protocol. The HP mean, mHP, was higher in
ASYMP individuals than in NMC subjects. The HP variance,
s2HP, was comparable in all the populations. According to the
pathology, the QT mean, mQT, was longer in ASYMP and SYMP
patients than in NMC individuals. The QT variance, s2QT,
separated ASYMP and SYMP patients with s2QT larger in
ASYMP individuals than in SYMP ones.
Table 2 shows the same parameters reported in Tab.1
computed in the DAY-NIGHT protocol. In both ASYMP and
SYMP patients mHP and mQT were longer during NIGHT than
during DAY. In SYMP group s2HP increased during NIGHT,
while in the ASYMP group s2QT decreased during NIGHT.
Remarkably, during DAY s2QT was able to separate ASYMP
subjects from SYMP ones. Indeed, during DAY s2QT of the
SYMP group was smaller than that of the ASYMP one.
Table 3 shows the same parameters reported in Tabs.1,2
computed in the BBoff-BBon protocol. In both ASYMP and
SYMP subjects beta-blocker therapy lengthened mHP but only mQT
in SYMP patients was significantly increased. In the SYMP group
s2HP was larger BBon than BBoff, while in ASYMP group beta-
blocker therapy significantly reduced s2QT. Given the same
experimental condition (i.e. BBoff or BBon) mHP, s
2
HP and s
2
QT
were able to differentiate ASYMP individuals from SYMP ones.
Indeed, BBon mHP was shorter and s
2
HP was larger in the SYMP
group than in the ASYMP one and BBoff s2QT was smaller in the
SYMP group than in the ASYMP one.
Comparison between RMSE indexes derived from HP and
QT series
Figure 1 shows RMSE mean (plus standard deviation) at short
time scale (i.e. t=1, Figs.1a,d,g), RMSEt=1, at medium time
scales (i.e. t=2–4 Figs.1b,e,h), RMSEt=2–4, and at long time
scales (i.e. t=5–12, Figs.1c,f,i), RMSEt=5–12, as a function of the
series (i.e. HP and QT). RMSE mean was computed by pooling
together NMC, ASYMP and SYMP individuals BBoff during
DAY in Figs.1a,b,c, ASYMP and SYMP subjects BBoff during
NIGHT in Figs.1d,e,f, and ASYMP and SYMP individuals BBon
during DAY in Figs.1g,h,i. BBoff during DAY RMSEt=1 and
RMSEt=2–4 were significantly larger in the QT series than in the
HP one. Conversely, the reverse situation was observed in the case
of RMSEt=5–12. Similar results were found BBoff during NIGHT
and BBon during DAY. However, the difference between
RMSEt=1 indexes assessed over HP and QT series BBoff during
NIGHT (Fig.1d) and BBon during DAY (Fig.1g) was less evident
than BBoff during DAY (Fig.1a). RMSEt=2–4 exhibited the same
trend (Figs.1b,e,h). The difference between RMSE indexes
assessed over HP and QT series remained stable in the case of
RMSEt=5–12 (Figs.1c,f,i).
RMSE at short time scale (t= 1) in NMC, ASYMP and
SYMP groups
Figure 2 shows RMSE mean (plus standard deviation) at short
time scale (i.e. t=1) as derived from HP and QT series (i.e.
RMSEHP,t=1 and RMSEQT,t=1) in Figs.2a,c,e and Figs.2b,d,f
respectively. RMSEt=1 was unable to separate groups (i.e. NMC,
ASYMP and SYMP). This conclusion held for any series (i.e. HP
or QT) and for any protocol (i.e. NMC-MC, DAY-NIGHT or
BBoff-BBon). In both ASYMP and SYMP groups RMSEHP,t=1
significantly increased during NIGHT compared to DAY (Fig.2c)
and BBon compared to BBoff (Fig.2e). While RMSEQT,t=1
significantly decreased during NIGHT compared to DAY in both
Table 1. Time domain indexes derived from HP and QT series
in the NMC-MC protocol.
NMC (n=14) ASYMP (n=11) SYMP (n=23)
mHP [ms] 697.66100.6 847.96143.8
1 761.3695.0
s2HP [ms
2] 1195.86711.8 1471.861048.1 1382.961000.6
mQT [ms] 317.6639.2 422.2651.7
1 408.6642.41
s2QT [ms
2] 186.06243.3 271.46212.0 115.4648.8u
mHP = HP mean; s
2
HP = HP variance; mQT = QT mean; s
2
QT = QT variance;
NMC = non mutation carrier group; ASYMP = asymptomatic group; SYMP =
symptomatic group. Results are reported as mean 6 standard deviation. The
symbol 1 indicates p,0.05 versus NMC individuals. The symbol u indicates
p,0.05 versus ASYMP subjects.
doi:10.1371/journal.pone.0093808.t001
Table 2. Time domain indexes derived from HP and QT series
in the DAY-NIGHT protocol.
DAY NIGHT
ASYMP
(n=11)
SYMP
(n=23)
ASYMP
(n=11)
SYMP
(n=23)
mHP [ms] 847.96143.8 761.3695.0 1022.66136.3
* 952.46117.1*
s2HP
[ms2]
1471.861048.1 1382.961000.6 1814.861619.9 2029.061897.3*
mQT [ms] 422.2651.7 408.6642.4 447.5642.1
* 445.3631.2*
s2QT
[ms2]
271.46212.0 115.4648.8# 95.6675.1* 85.2667.1
mHP = HP mean; s
2
HP = HP variance; mQT = QT mean; s
2
QT = QT variance;
DAY = daytime; NIGHT = nighttime; ASYMP = asymptomatic group; SYMP =
symptomatic group. Results are reported as mean 6 standard deviation. The
symbol * indicates p,0.05 within the same group (i.e. ASYMP or SYMP) versus
DAY. The symbol # indicates p,0.05 within the same period of analysis (i.e.
DAY or NIGHT) versus ASYMP subjects.
doi:10.1371/journal.pone.0093808.t002
Table 3. Time domain indexes derived from HP and QT series
in the BBoff-BBon protocol.
BBoff BBon
ASYMP
(n=7)
SYMP
(n=22)
ASYMP
(n=7)
SYMP
(n=22)
mHP [ms] 855.86143.5 757.9695.8 1038.26176.0
* 927.86117.2#,*
s2HP [ms
2] 1122.261014.7 1437.96987.9 1581.061081.2 2667.961910.4#,*
mQT [ms] 424.0657.6 406.5642.1 426.7658.0 429.8629.3
*
s2QT [ms
2] 292.96258.5 116.1649.8# 110.96105.3* 115.5685.3
mHP = HP mean; s
2
HP = HP variance; mQT = QT mean; s
2
QT = QT variance;
BBoff = off beta-blocker therapy; BBon = on beta-blocker therapy; ASYMP =
asymptomatic group; SYMP = symptomatic group. Results are reported as
mean 6 standard deviation. The symbol * indicates p,0.05 within the same
group (i.e. ASYMP or SYMP) versus BBoff. The symbol # indicates p,0.05 within
the same therapy (i.e. BBoff or BBon) versus ASYMP subjects.
doi:10.1371/journal.pone.0093808.t003
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ASYMP and SYMP patients (Fig.2d), beta-blocker therapy did not
modify RMSEQT,t=1 (Fig.2f).
RMSE at medium time scales (t= 2–4) in NMC, ASYMP
and SYMP groups)
Figure 3 shows RMSE mean (plus standard deviation) at
medium time scales (i.e. t=2–4) as derived from HP and QT
series (i.e. RMSEHP,t=2–4 and RMSEQT,t=2–4) in Figs.3a,c,e and
Figs.3b,d,f respectively. In the NMC-MC protocol RMSEHP,t=2–4
(Fig.3a) and RMSEQT,t=2–4 (Fig.3b) were able to separate the
ASYMP group from the SYMP one with both indexes smaller in
the ASYMP group. RMSEQT,t=2–4 differentiated the ASYMP
group from the NMC one as well, being RMSEQT,t=2–4 in the
ASYMP group smaller than in NMC one (Fig.3b). In the DAY-
NIGHT protocol (Figs.3c,d) and in the BBoff-BBon protocol
(Figs.3e,f) RMSEHP,t=2–4 and RMSEQT,t=2–4 separated the
ASYMP group from the SYMP one only during DAY with both
RMSEHP,t=2–4 and RMSEQT,t=2–4 higher in SYMP patients
than in ASYMP group. DAY-NIGHT variations and the effect of
the therapy were observable only in RMSEHP,t=2–4 in ASYMP
group with RMSEHP,t=2–4 significantly increased during NIGHT
(Fig.3c) and BBon (Fig.3e) and only in RMSEQT,t=2–4 in SYMP
group with RMSEQT,t=2–4 significantly decreased during NIGHT
(Fig.3d) and BBon (Fig.3f).
RMSE at long time scales (t=5–12) in NMC, ASYMP and
SYMP groups
Figure 4 shows RMSE mean (plus standard deviation) at long
time scales (i.e. t=5–12) as derived from HP and QT series (i.e.
RMSEHP,t=5–12 and RMSEQT,t=5–12) in Figs.4a,c,e and
Figs.4b,d,f respectively. In the NMC-MC protocol
RMSEHP,t=5–12 and RMSEQT,t=5–12 were able to separate the
SYMP group from NMC and ASYMP individuals with
RMSEHP,t=5–12 and RMSEQT,t=5–12 in the SYMP group larger
than those in the NMC and ASYMP ones (Figs.4a,b). In the DAY-
NIGHT protocol RMSEHP,t= 5–12 (Fig.4c) and RMSEQT,t=5–12
(Fig.4d) separated the ASYMP group from the SYMP one only
during DAY with RMSEHP,t=5–12 and RMSEQT,t=5–12 larger in
SYMP individuals. Significant DAY-NIGHT variations were
observed only in SYMP individuals (Figs.4c,d) with both
RMSEHP,t=5–12 and RMSEQT,t=5–12 smaller during NIGHT
(Figs.4c,d). In the BBoff-BBon protocol RMSEHP,t=5–12 and
RMSEQT,t=5–12 distinguished ASYMP individuals from SYMP
ones both BBoff and BBon with both RMSEHP,t=5–12 and
RMSEQT,t=5–12 larger in SYMP individuals (Figs.4e,f). As to the
effect of the beta-blocker therapy, it was visible only in SYMP
patients over RMSEHP,t=5–12 and RMSEQT,t=5–12 (Fig.4e,f). The
effect of the therapy was to reduce both RMSEHP,t=5–12 (Fig.4e)
and RMSEQT,t=5–12 (Fig.4f).
Figure 1. Comparison between RMSE indexes derived from HP and QT series. RMSE mean (plus standard deviation) assessed at short time
scale (i.e. t=1), RMSEt= 1 (a,d,g), at medium time scales (i.e. t=2–4), RMSEt= 2–4 (b,e,h), and at long time scales (i.e. t= 5–12), RMSEt= 5–12, (c,f,i) is
shown as a function of the time series (i.e. HP and QT). RMSEt= 1, RMSEt= 2–4, and RMSEt= 5–12 were obtained by pooling RMSE values computed BBoff
during DAY (a,b,c), BBoff during NIGHT in (d,e,f), and BBon during DAY (g,h,i), The symbols 1 and u indicate a significant difference with p,0.001 and
p,0.05 respectively.
doi:10.1371/journal.pone.0093808.g001
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Discussion
The major findings of the study can be summarized as follows.
First, we confirmed the protective role of having longer HP in
LQT1 syndrome [4] and the larger vagal reactivity of SYMP
subjects [4,5] as indicated by a larger HP variance during
NIGHT. As a new finding the increased vagal reactivity appeared
to be associated with a reduced sympathetic control in the SYMP
group as indicated by the low QT variance during DAY.
Second, HP and QT variability were characterized by different
levels of complexity and this difference was linked to the activity of
the autonomic nervous system. At short time scale the sympathetic
branch of the autonomic nervous system played a central role in
keeping high the complexity of the QT series, while the vagal
branch of the autonomic nervous system was involved in keeping
high the complexity of the HP series. At long time scales
sympathetic nervous system was involved in modulating the
complexity of both HP and QT series even though the
contribution to the complexity of the HP and QT variability
was different.
Third, complexity indexes derived from HP and QT series at
short time scales could not to differentiate the groups under
scrutiny, while those at medium and long time scales could. More
specifically, complexity markers at medium and long time scales
assessed over both HP and QT series increased in SYMP group
compared to the ASYMP one, thus suggesting a higher complexity
of the sympathetic control in SYMP group.
Figure 2. RMSE at short time scale over HP and QT series. RMSE mean (plus standard deviation) assessed at short time scale (i.e. t= 1) over HP
series, RMSEHP,t= 1 (a,c,e), and QT series, RMSEQT,t= 1 (b,d,f), is shown as a function of the experimental protocol. RMSEHP,t= 1 and RMSEQT,t= 1 are
depicted as a function of the group of subjects in the NMC-MC protocol in (a) and (b) respectively, as a function of the period of analysis in the DAY-
NIGHT protocol in (c) and (d) respectively, and as a function of the therapy in the BBoff-BBon protocol in (e) and (f) respectively. The gray, dark and
white bars are relevant to NMC, ASYMP and SYMP individuals, respectively. The symbols * indicates a significant difference between experimental
conditions (i.e. DAY versus NIGHT, BBoff versus BBon) within the same group with p,0.05.
doi:10.1371/journal.pone.0093808.g002
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Fourth, complexity indexes derived from HP and QT series at
long time scales exhibited a tendency toward a reduction overnight
and under beta-adrenergic therapy, thus indicating a beneficial
effect of the therapy and a reduced cardiac risk while sleeping.
We conclude that multiscale complexity analysis is helpful in
identifying LQT1 patients with different cardiac risks and
insightful in describing the cardiovascular control of LQT1
patients.
Time domain analysis of HP and QT variability
We confirmed that ASYMP patients had longer HP [4]. This
characteristic can be considered as a protective factor because, in
presence of a relatively immutable duration of the T-wave, it
decreases the likelihood that a new ventricular depolarization
could occur in the wrong phase of the T wave. This observation
substantiates the protective effect of the beta-blocker therapy in
LQT1 patients because it leads to a HP lengthening [36]. Since
the HP prolongation induced by the beta-blocker therapy was
larger in ASYMP patients than in SYMP ones, it could be
conjectured that the beta-blocker treatment is more effective in
ASYMP individuals than in SYMP one. We observed that HP
mean was longer during NIGHT than during DAY in both
ASYMP and SYMP group. Since having a longer HP might be
safer in LQT1 patients [4], this finding might explain why LQT1
individuals are less at risk during NIGHT than during DAY [3].
According to the LQT1 phenotype QT mean was longer in
ASYMP and SYMP groups compared to the NMC one. Circadian
rhythm of the QT mean was preserved in both ASYMP and
SYMP, thus suggesting that the positive relation linking HP to QT
was maintained in LQT1 patients. In SYMP patients the power of
the HP variability increased during NIGHT in absence of therapy,
as a likely result of a vagal enhancement [6,8], and BBon during
DAY, as a likely result of the beta-adrenergic blockade [37]. This
result suggests a more reactive vagal control in SYMP patients
Figure 3. RMSE at medium time scales over HP and QT series.
RMSE mean (plus standard deviation) assessed at medium time scales
(i.e. t= 2–4) over HP series, RMSEHP,t= 2–4 (a,c,e), and QT series,
RMSEQT,t= 2–4 (b,d,f), is shown as a function of the experimental
protocol. RMSEHP,t= 2–4 and RMSEQT,t= 2–4 are depicted as a function of
the group of subjects in the NMC-MC protocol in (a) and (b)
respectively, as a function of the period of analysis in the DAY-NIGHT
protocol in (c) and (d) respectively, and as a function of the therapy in
the BBoff-BBon protocol in (e) and (f) respectively. The gray, dark and
white bars are relevant to NMC, ASYMP and SYMP individuals,
respectively. The symbol * indicates a significant difference between
experimental conditions (i.e. DAY versus NIGHT, BBoff versus BBon)
within the same group with p,0.05. The symbol # indicates a
significant difference between groups within the same experimental
conditions (i.e. DAY, NIGHT, BBoff or BBon) with p,0.05.
doi:10.1371/journal.pone.0093808.g003
Figure 4. RMSE at long time scales over HP and QT series.
RMSE mean (plus standard deviation) assessed at long time scales (i.e.
t = 5–12) over HP series, RMSEHP,t = 5–12 (a,c,e), and QT series,
RMSEQT,t= 5–12 (b,d,f), is shown as a function of the experimental
protocol. RMSEHP,t= 5–12 and RMSEQT,t= 5–12 are depicted as a function of
the group of subjects in the NMC-MC protocol in (a) and (b)
respectively, as a function of the period of analysis in the DAY-NIGHT
protocol in (c) and (d) respectively, and as a function of the therapy in
the BBoff-BBon protocol in (e) and (f) respectively. The gray, dark and
white bars are relevant to NMC, ASYMP and SYMP individuals,
respectively. The symbol * indicates a significant difference between
experimental conditions (i.e. DAY versus NIGHT, BBoff versus BBon)
within the same group with p,0.05. The symbol # indicates a
significant difference between groups within the same experimental
conditions (i.e. DAY, NIGHT, BBoff or BBon) with p,0.05.
doi:10.1371/journal.pone.0093808.g004
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[4,5]. This observation is in agreement with the finding that the
cardiac baroreflex sensitivity, another index of vagal modulation,
was increased in SYMP patients [4] and that SYMP patients were
characterized by an exaggerated bradycardia following an exercise
stress test [5]. As a novel finding the ASYMP patients were
characterized by a higher QT variance compared to the SYMP
ones during DAY in absence of therapy, thus suggesting that a
higher sympathetic modulation might be a protective factor in
ASYMP patients because it is helpful in limiting the vagal control
and its responsiveness to challenges. The observed reduction of the
QT variance in ASYMP subjects BBoff during NIGHT and BBon
during DAY confirms that the amount of the QT variability is
under sympathetic control [9–12,16,17,21,38].
Complexity analysis of HP and QT series provides non
redundant information in LQT1 patients
In LQT1 population we confirm that QT complexity indexes
provide different information from the HP complexity ones [26].
Differences depend on the temporal scales under scrutiny. While
at short and medium temporal scales the complexity of the QT
series was larger than that of the HP series [39,40], the reverse
situation was found at long temporal scales [26]. This result was
independent of the period of analysis (i.e. DAY or NIGHT) and of
the therapy (i.e. BBoff or BBon). The larger complexity of QT
series at short and medium temporal scales suggests that the QT
variability cannot be considered merely the consequence of the HP
changes inducing QT variations through the QT-HP relation
[41]. Inputs modifying QT interval and its variability indepen-
dently of HP changes [10,13,42–44] tend to increase the
complexity of the QT series compared to that of the HP one.
We suggest that the complexity of the QT series at short and
medium time scales was kept high by QT dynamics unrelated to
HP changes. Since these inputs increase during the sympathetic
activation induced by an orthostatic challenge [10] and mental
stress [13], it is not surprising to find out that the difference
between QT and HP complexity tends to decrease during NIGHT
and in presence of beta-blocker therapy. Also the smaller
complexity of the QT series at long time scales compared to that
of the HP series is incompatible with an all-pass QT-HP transfer
function. It might be hypothesized that inputs at long time scales
targeting the sinus node cannot reach ventricles, thus suggesting
that the control of the ventricles at long time scales is much simpler
than that of the sinus node.
Link between complexity indexes at short time scale and
autonomic regulation in LQT1 population
Complexity of the HP series at short temporal scale is mainly
under vagal control. Indeed, it decreased significantly after
complete cholinergic blockade induced by a high dose adminis-
tration of atropine [45] and during vagal withdrawal induced by
head-up tilt [23] or active standing [46]. The present study
confirms the link between complexity of the HP series at short time
scale and vagal control: indeed, complexity of the HP series
increased during NIGHT [47], as a likely consequence of the
increased importance of vagal modulation, and in presence of
beta-blocker therapy, as a likely consequence of the sympathetic
blockade leading to an augmented respiratory sinus arrhythmia
[37]. The increase was significant in both SYMP and ASYMP
patients, thus suggesting that the circadian rhythm was preserved
and effects of beta-blocker therapy were evident in both groups.
Fewer studies tried to establish an association between
complexity of QT series at short time scale and autonomic
modulation. Some studies suggested that an augmented complex-
ity of QT series could be interpreted as a marker of a higher
sympathetic drive [40,48]. The present study detected a reduction
of complexity of the QT series at short time scale during NIGHT.
Since QT series is mainly under sympathetic control [9–
12,16,17,21,38], this tendency suggests a simplification of the
cardiac control directed to ventricles during NIGHT, as a likely
result of the vagal enhancement. However, since beta-blocker
therapy did not affect the complexity of the QT series at short time
scale, the association between the complexity of the QT series at
short time scale and sympathetic control appears to be weak, thus
prompting for the search of this association at time scales more
compatible with the sluggishness of the sympathetic control.
Link between complexity indexes at medium and long
time scales and autonomic regulation in LQT1
population
The physiological correlates of the complexity of the HP series
assessed at medium and long temporal scales are not completely
identified. Since complexity indexes at medium time scales
assessed from the QT series and at long time scales estimated
from both HP and QT series decreased during sympathetic
withdrawal occurring during NIGHT and after beta-adrenergic
blockade, we suggest that these parameters are under sympathetic
control. This observation is in agreement with the finding that
complexity indexes at long temporal scales increased during the
sympathetic activation induced by active standing [46]. It is worth
noting that, although complexity indexes at medium and long time
scales exhibited similar trends, the ones at long time scales
appeared to be more powerful in suggesting the simplification of
the sympathetic control during NIGHT and due to the beta-
blocker treatment. As a consequence, we recommend the sole
calculation of complexity indexes at long time scales in future
applications aiming at extracting indexes linked to the sympathetic
function.
Complexity analysis at short time scale was unable to
distinguish SYMP patients from ASYMP ones in LQT1
population
One of the most important finding of this study is that the most
commonly utilized index of complexity based on entropy (i.e.
RMSE at short time scale) [34] failed to differentiate MC
individuals from NMC patients and to separate MC individuals
into SYMP and ASYMP subjects. This finding was robust because
it did not depend on the considered variability series (i.e. HP or
QT series) and on the experimental protocol (i.e. NMC-MC,
DAY-NIGHT and BBoff-BBon protocols). This conclusion
substantiates the need of adopting the MSE approach in this
specific study. A likely explanation of this disappointing result
might be the low temporal resolution of HP and QT measures
derived from a historical database of Holter recordings [27,28].
This low temporal resolution might increase the corrupting
influence of noise, especially at high frequencies (i.e. close to
superior limit of the HF band), thus limiting the information
content of faster temporal scales and reducing the statistical power
of RMSE indexes at short time scale.
Complexity analysis at medium and long time scales did
distinguish SYMP patients from ASYMP ones in LQT1
population
At difference with complexity indexes at short time scale, the
ones at medium and long time scales did distinguish ASYMP
individuals from SYMP ones especially during DAY. Complexity
of the cardiac control at medium and long time scales was larger in
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SYMP subjects than in ASYMP individuals. Since the increase
was observed in the case of both indexes at medium and long time
scales, it cannot be ascribed to oscillations in the HF band but to
slower temporal scales (i.e. in the LF band or even below the
inferior limit of the LF band). Differences in vagal control between
SYMP and ASYMP individuals cannot fully explain this
differentiation. Indeed, if vagal control was responsible for the
increase of the complexity of the cardiac control at medium and
long time scales, the complexity indexes at medium and long time
scales derived from the QT series would have remained
unchanged because QT variability is more responsive to
sympathetic control and largely unaffected by the vagal control
[21]. Therefore, data suggest that in SYMP patients the
sympathetic control impinging both sinus node and ventricles is
more complex than that of ASYMP subjects. Since ASYMP
subjects are characterized by a lower probability of cardiac events,
we suggest that a smaller complexity of the cardiovascular control
is protective. In addition, since complexity indexes assessed from
the QT series at medium time scales and assessed from HP and
QT series at long time scales decreased during NIGHT and due to
the beta-blocker therapy in SYMP subjects, complexity analysis
confirms that NIGHT is a safer period for LQT1 patients and
beta-blocker therapy is beneficial. This conclusion is supported
also by the reduced differences between ASYMP and SYMP
patients during NIGHT and after beta-blocker therapy.
Conclusions
RMSE was applied to assess the complexity of the cardiac
control directed to sinus node and to ventricles in NMC and MC
individuals all being descendants of the same South African family.
The study demonstrates the different information carried by
markers of complexity derived from the HP and QT variability
and the importance of assessing complexity as a function of the
temporal scales in LQT1 population. Indeed, while the complexity
of the HP series at short time scale was under vagal control, the
complexity of the HP and QT variability at long time scales was
under sympathetic control. In addition, the study proves the
clinical relevance of the complexity analysis of the cardiac control
in LQT1 patients. Indeed, the detected ability of the complexity
indexes at long time scales to separate the ASYMP group from the
SYMP one suggests that the complexity of the sympathetic control
acts as an arrhythmic risk modifier in LQT1 patients with
individuals characterized a larger complexity having a higher
probability of belonging to the SYMP group. Remarkably, the
separation between ASYMP and SYMP groups did not necessitate
any complex procedure, being achieved over routine 24-hour
Holter electrocardiographic recordings. Since conclusions were
achieved over electrocardiographic traces with low temporal
resolution, the proposed analysis is suitable for retrospective
applications to historical databases. In addition, findings support
the suitability of the most common LQT1 therapy based on beta-
adrenergic blockade in limiting the arrhythmic risk in LQT1
patients. Indeed, given that a high complexity of the sympathetic
control is a risk factor in LQT1 patients, beta-adrenergic therapy
can successfully limit it and reduce the differences between
ASYMP and SYMP subjects.
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